75 filings
Page 3 of 4
8-K
rjuz1bfr60 9hnk
4 Aug 20
Departure of Directors or Certain Officers
4:16pm
8-K
14qb6ex yqymgwb42
11 May 20
Amneal Reports First Quarter 2020 Financial Results
6:47am
8-K
2eut30m1id
8 May 20
Departure of Directors or Certain Officers
7:43am
8-K/A
4yyqh0q03c
17 Apr 20
Independent Auditor’s Report
4:05pm
8-K
s4lke005an46p4hlc
12 Mar 20
Amneal Pharmaceuticals Appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer
5:19pm
8-K
bc5643c 9r899m1pdz
26 Feb 20
Departure of Directors or Certain Officers
4:55pm
8-K
6wi6pge 6fkr5et5
26 Feb 20
Amneal Reports Fourth Quarter and Full Year 2019 Financial Results
6:50am
8-K/A
80m70m2o34ztp
20 Feb 20
Departure of Directors or Certain Officers
4:49pm
8-K/A
44s2v egias9cxix
20 Feb 20
Departure of Directors or Certain Officers
4:47pm
8-K
88pvwtjihf641gp
4 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
b8rud uymwbh5
15 Jan 20
Regulation FD Disclosure
10:32am
8-K
r4wvcek8cq db21q6n8z
16 Dec 19
Amneal Appoints Jeff George, John Kiely and Shlomo Yanai to Board of Directors
4:50pm
8-K
t4b7r63n71zou vlt18y
10 Dec 19
Amneal to Acquire Majority Interest in AvKARE, Enhancing Access
4:51pm
8-K
azna3et
6 Nov 19
Amneal Reports Third Quarter 2019 Financial Results
6:54am
8-K
ou1qcts 8r
11 Oct 19
Submission of Matters to a Vote of Security Holders
12:07pm
8-K
isz75
5 Aug 19
Amneal Reports Second Quarter 2019 Financial Results
6:20am
8-K
qgu03p9 3q
5 Aug 19
Paul Meister Elected Chairman of the Board
6:13am
8-K
79par8rj7y zova
10 Jul 19
Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth
4:52pm
8-K
5j3h1f
9 May 19
Departure of Directors or Certain Officers
4:43pm
8-K
blhlfb
9 May 19
Amneal Reports First Quarter 2019 Financial Results
6:42am